Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07734610
PHASE1
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
Sponsor: Merck Sharp & Dohme LLC
View on ClinicalTrials.gov
Summary
The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy participants.
Official title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of Nemtabrutinib in Participants With Severe Renal Impairment
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-08-17
Completion Date
2027-02-01
Last Updated
2026-07-29
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Nemtabrutinib
Oral administration